Clinical Trials in Denver

Showing 5561-5580 of 18,161 trials

NB-001 in Children and Adolescents With 22q11 Deletion Syndrome

NCT05290493

This is a Phase 2, randomized, placebo-controlled crossover trial to assess the safety and efficacy of NB-001 in children and adolescents with 22q11DS that manifest commonly associated neuropsychiatric symptoms.

22q11 Deletion Syndrome

Nobias Therapeutics, Inc.37 participantsStarted Feb 2022

Aurora, Colorado, United States • Philadelphia, Pennsylvania, United States • Seattle, Washington, United States +1 more locations

TERMINATEDPhase 18.4 miles

(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations

NCT05241873

This is a Phase 1/2, open-label first-in-human study of the safety, pharmacokinetics (PK), pharmacodynamics, and anti-tumor activity of BLU-451 monotherapy and BLU-451 in combination with platinum-based chemotherapy (carboplatin and pemetrexed). All participants will receive BLU-451 on a 21-day treatment cycle.

Lung Neoplasm MalignantCarcinoma, Non-Small-Cell LungRespiratory Tract Neoplasms+17 more

Blueprint Medicines Corporation103 participantsStarted Mar 2022

Duarte, California, United States • Los Angeles, California, United States • Aurora, Colorado, United States +20 more locations

NB-001 in Children and Adolescents With 22q11 Deletion Syndrome

(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations

Find Trials by Condition in Denver

A Focus Group Study to Explore Smoking Triggers and Acceptability of Just-in-time Adaptive Intervent

Characterization of Endocannabinoid and Endogenous Opioid Levels in Adolescents With Cannabis Use Disorder

A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies

Study on BI 54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Medium Dose Inhaled Corticosteroid (ICS).

Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Upadacitinib in Pediatric Participants With Severe Atopic Dermatitis

Futibatinib Versus Gemcitabine-Cisplatin Chemotherapy as First-Line Treatment of Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements

A Study of SGN-ALPV in Advanced Solid Tumors

LDK378 Versus Chemotherapy in ALK Rearranged (ALK Positive) Patients Previously Treated With Chemotherapy (Platinum Doublet) and Crizotinib

Clinical Trial to Assess Efficacy and Safety of the Human Anti-CD38 Antibody Felzartamab (MOR202) in IgA Nephropathy

A Study of Imvotamab in Severe Systemic Lupus Erythematosus

A Trial of a Novel XPO1 Inhibitor in Participants With Advanced Solid Tumors

Open-Label Study of Setmelanotide in Hypothalamic Obesity

Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers

A Follow up Study of Patients Treated With Imlifidase Prior to Kidney Transplantation

A Study of the Safety and Tolerability in Participants With PIK3CA-related Overgrowth Spectrum or Proteus Syndrome Who Are Being Treated With Miransertib (MK-7075) in Other Studies (MK-7075-006)

Foot and Ankle Post-operative Oedema Management Using Geko™

A Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of PGDM1400LS Alone and in Combination With VRC07-523LS and PGT121.414.LS in Healthy, HIV-uninfected Adult Participants